Showing results (191-200 of 398) with videos related to

Sort By:
Pageof 40
Vascular Health and Risk Management|August 2, 2014
XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillationA John Camm, Pierre Amarenco, Sylvia Haas, et al.
British Journal of Clinical Pharmacology|November 19, 2015
Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co-medication interactionsReinhold Kreutz, Sylvia Haas, Gerlind Holberg, et al.
Vascular Health and Risk Management|June 16, 2012
Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgeryAlexander G G Turpie, André C Schmidt, Reinhold Kreutz, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 19, 2018
Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1Craig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.
Atmospheric Measurement Techniques|April 19, 2019
Evaluation and environmental correction of ambient CO2 measurements from a low-cost NDIR sensorCory R Martin, Ning Zeng, Anna Karion, et al.
Canadian Geriatrics Journal : CGJ|November 27, 2013
The Value of Admission Clinical Data for Diagnosing Heart Failure in Long-term CareGeorge A Heckman, Andrea D Foebel, Joel A Dubin, et al.
Clinical Cardiology|September 8, 2020
Impact of gender: Rivaroxaban for patients with atrial fibrillation in the XANTUS real-world prospective studyA John Camm, Pierre Amarenco, Sylvia Haas, et al.
Circulation|September 1, 1981
Clinical validity of a negative venogram in patients with clinically suspected venous thrombosisR Hull, J Hirsh, D L Sackett, et al.
Pageof 40